Search

everythinglearnresearchcommunity

for

Search:↓

The conversation is about a user seeking advice on adding GHK-Cu to RU58841 for hair loss treatment, while already using oral minoxidil, dutasteride, ketoconazole shampoo, and considering LLLT. They are unsure about the concentration and carrier solution for GHK-Cu.

Adding Pyri to a hair loss treatment stack. The user is inquiring about its effectiveness and side effects.

A user is creating a custom topical hair regrowth serum using minoxidil, bimatoprost, tretinoin, castor oil, and hyaluronic acid. They are also using dutasteride, oral minoxidil, and castor oil in their current regimen.

The conversation is about the use of peptide therapies for hair loss, specifically GHK-CU, ZN-Thymulin, and PTD-DBM. The user is seeking feedback on the effectiveness of these treatments from those who have tried them.

PP405 is humorously suggested as a new hair loss cure with "shocking results." The conversation includes references to Minoxidil, finasteride, and RU58841.

PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.

Minoxidil use may cause changes in hair texture, with some users experiencing straighter hair and others noticing darker hair. Users are uncertain if these changes are permanent or temporary.

Finasteride users often experience itchy scalps, which may improve over time, but many rely on ketoconazole shampoo to manage symptoms. Some users find that finasteride helps with hair shedding, but not with scalp irritation, which may require additional treatment.

A user is frustrated with slow hair regrowth despite using minoxidil, finasteride, and microneedling. Others suggest trying dutasteride or oral minoxidil for potentially better results.

There is no permanent cure for hair loss; treatments like finasteride, minoxidil, and hair transplants require ongoing use and are not universally effective. Genetic complexity and financial incentives for ongoing treatments hinder the development of a definitive cure.

Hair cloning and new treatments like ET-02, Veradermics (vdphl01), and wound-induced hair neogenesis show promise but are not yet widely available. Current effective treatments include minoxidil, finasteride, and dutasteride, with early intervention being crucial for better outcomes.

Hair texture changes, such as hair becoming curly, are common when using treatments like finasteride and minoxidil. Users report various experiences with these treatments, including changes in hair density and texture, with some using additional products like alfatrodial, fluridil, and pyrilutamide for hair maintenance.

AMP-303 and AMP-601 are new hair loss treatments targeting dermal papilla cells, with AMP-303 showing early efficacy in transitioning vellus hairs to terminal hairs after one injection. Further clinical trials are planned, and these treatments are seen as promising due to their biologic approach and less frequent application compared to daily treatments.

A 31-year-old is happy with hair regrowth and thickening after using 0.5 mg dutasteride daily and 5% topical minoxidil. Initial results appeared in six months, with continued improvement over time.

Baldness is difficult to cure because current treatments like finasteride, dutasteride, and minoxidil only prevent hair shedding, and new developments are mostly ineffective. Botox shows potential in aiding skin regeneration and hair growth, but maintenance therapy with treatments like dutasteride and minoxidil may still be necessary.

GT20026 is discussed as a potential treatment for hair loss that targets androgen receptors without affecting hormone levels, but it may not promote significant regrowth. It is expected to be available by 2028, with other treatments like Breezula and Clascoterone also mentioned.

Ketoconazole shampoo can be very drying, especially for curly hair, and may not be suitable for those who need to maintain moisture. Some users suggest using oils or masks to mitigate dryness, while others recommend avoiding it unless necessary for conditions like dandruff.

Oral minoxidil caused changes in hair texture, making it curly, dry, and lifeless, raising concerns about whether this is a temporary phase or permanent. Users discussed potential side effects of oral minoxidil, including heart issues, and suggested consulting a dermatologist and monitoring health markers.

The user is using Dutasteride and Minoxidil for hair loss and is considering a shorter buzz cut to manage the appearance of thinning at the crown. They are unsure if a #1 buzz cut would look better than a #3 while waiting for the treatment to take effect.

The user is using 1 mg finasteride daily, Rogaine foam once a day, and Nizoral 2-3 times a week for hair regrowth. Progress is visible, but full effects of finasteride may take 12-18 months, and patience is advised.

Pregnancy can temporarily reverse hair loss in women, but attempts to mimic pregnancy hormones with treatments like contraceptive pills, spironolactone, estradiol, progesterone, finasteride, and minoxidil have been ineffective. The discussion highlights the need for research into the hormonal mechanisms of pregnancy that affect hair regrowth.

Topical roflumilast is effective for reducing inflammation in various scalp conditions like seborrheic dermatitis, psoriasis, and eczema, but not proven to stop scarring alopecia. Alternatives like apremilast and Vtama are also discussed for their anti-inflammatory benefits.

Clascoterone is seen as a promising topical treatment for hair loss, similar to finasteride but without side effects, though concerns exist about its long-term effectiveness. Other treatments discussed include topical minoxidil, ketoconazole, microneedling, and oral options like dutasteride and minoxidil.

People shared their experiences with coffee consumption and hair loss, with mixed results. Some noticed more hair loss with increased caffeine, while others saw no effect or even hair regrowth, often using treatments like finasteride and minoxidil.

PP405 is a promising hair growth stimulant but not a cure for advanced hair loss, as it may only help dormant follicles. Treatments like Minoxidil, Finasteride, and Dutasteride are discussed, with emphasis on early intervention for effectiveness.

Finasteride 5mg tablets can be cut into one-fifth to treat hair loss. This method is considered due to cost concerns.

The conversation discusses using a custom topical from Skin Medicinals containing latanoprost for hair loss, which helps move hairs into the anagen phase. The user is curious about the cost and effectiveness of this treatment.

A South Korean company, Therazyne, has developed a promising hair loss treatment using a WNT chain surrogate that binds to Frizzled 7, with human follicle testing expected soon. Current treatments like minoxidil and finasteride are not seen as cures, and while optimism exists for future solutions like PP405, approval processes are lengthy.

The user diagnosed with DUPA tried treatments like dutasteride, finasteride, RU58841, and minoxidil without success and is considering a hair system. They hope for a future cure, possibly with PP405, and others suggest options like scalp biopsy and SMP.

Microneedling on the vertex may require trimming hair to ensure needles reach the scalp effectively. Using a needle length of 1.0–1.5 mm is suggested, and longer hair might get damaged if not cut.